Picard Medical to present preclinical Emperor TAH data and clinical outcomes at THT 2026

Picard Medical, Inc.

Dr. Andre Simon to deliver three presentations at THT 2026 conference (Mar 2-4, Boston) on SynCardia TAH and Emperor system.
Preclinical data for next-gen fully implantable Emperor system shows preserved physiologic performance; aims to eliminate pneumatic drivelines.
Registry analyses show SynCardia TAH outcomes beyond survival: organ recovery, functional improvement, transplant eligibility preservation.
Educational lecture covers future TAH evolution: earlier intervention, organ recovery, transition to durable long-term support.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.